Jennison Associates
MDCO

Jennison Associates’s Medicines Co MDCO Stock Holding History

Jennison Associates’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-832,646
Closed -$31.4M – 843
2016
Q3 		$31.4M Sell
832,646
-10,426
-1% -$393K 0.03% 348
2016
Q2 		$28.4M Sell
843,072
-148,536
-15% -$5.24M 0.03% 365
2016
Q1 		$31.5M Buy
991,608
+71,225
+8% +$2.33M 0.03% 352
2015
Q4 		$34.4M Buy
920,383
+21,068
+2% +$796K 0.03% 348
2015
Q3 		$34.1M Buy
899,315
+7,027
+0.8% +$247K 0.04% 363
2015
Q2 		$25.5M Buy
892,288
+8,978
+1% +$250K 0.02% 434
2015
Q1 		$24.8M Buy
883,310
+2,826
+0.3% +$79.4K 0.02% 421
2014
Q4 		$24.4M Sell
880,484
-970
-0.1% -$24K 0.02% 418
2014
Q3 		$19.7M Buy
881,454
+1,317
+0.1% +$33.4K 0.02% 437
2014
Q2 		$25.6M Sell
880,137
-424,599
-33% -$11.3M 0.02% 412
2014
Q1 		$37.1M Sell
1,304,736
-6,264
-0.5% -$207K 0.04% 373
2013
Q4 		$50.6M Buy
1,311,000
+12,098
+0.9% +$433K 0.05% 304
2013
Q3 		$43.5M Buy
1,298,902
+239,562
+23% +$7.63M 0.05% 321
2013
Q2 		$32.6M Buy
+1,059,340
New +$35.4M 0.04% 359

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

Jennison Associates's MDCO Position: Q4 2016 in Review

Jennison Associates sold out of Medicines Co (MDCO) in Q4 2016, closing a stake of 832,646 shares — an estimated $31.4M sold.

Jennison Associates first reported a position in MDCO in Q2 2013 and held it in 14 quarters. The position peaked at $50.6M in Q4 2013. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

  • Jennison Associates reported no remaining Medicines Co position as of Q4 2016 after selling out during the quarter.
  • Jennison Associates sold 832,646 Medicines Co shares in Q4 2016, an estimated $31.4M.
  • Jennison Associates first reported a position in Medicines Co in Q2 2013 and held it in 14 quarters.
  • Jennison Associates's Medicines Co position peaked at $50.6M in Q4 2013.
  • 195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on Jennison Associates's 13F filing for Q4 2016, filed 6 Feb 2017.